leadf
logo-loader
viewArix Bioscience PLC

Arix Bioscience investee company strengthens pipeline

The venture capital firm applauded the exclusive deal inked by Artios Pharma

Arix Bioscience PLC -
DDR is a network of cellular pathways that sense, signal and repair DNA lesion

Arix Bioscience PLC (LON:ARIX) said an investee company has “in-licensed” an ATR inhibitor programme from one of the world’s leading cancer centres and a venture capital firm.

Artios Pharma’s exclusive deal with The University of Texas MD Anderson Cancer Center and ShangPharma Innovation strengthens the company’s earlier-stage pipeline focused on the area of DNA damage response.

DDR is a network of cellular pathways that sense, signal and repair DNA lesions.

Surveillance proteins that monitor DNA integrity can activate cell cycle checkpoints and DNA repair pathways in response to DNA damage, to prevent the generation of potentially harmful mutations.

Arix investment director, Jonathan Tobin, who is also an Artios board member, said he was pleased to see the firm’s pipeline “continue to grow and mature”.  

“This deal, coupled with Artios’ significant expertise in this field, reinforces its position as the world leader in this exciting new space in oncology,” he added.

Quick facts: Arix Bioscience PLC

Price: 106 GBX

LSE:ARIX
Market: LSE
Market Cap: £143.8 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Arix Bioscience PLC named herein, including the promotion by the Company of Arix Bioscience PLC in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Market report: FTSE flounders as imminent Brexit talks loom

The FTSE is mixed this Tuesday despite the weaker pound. Sterling is still battling no deal Brexit fears as the UK Prime Minister Boris Johnson threatens that if no progress on the talks with the EU is made week, preparations for a no deal will be ramped up. Britain’s biggest sports retailer...

1 week, 4 days ago

2 min read